Presentation is loading. Please wait.

Presentation is loading. Please wait.

General Pathology Basic Principles of Cellular and Organ Pathology Steatosis. Mitochondrial and Peroxisomal Disorders. Jaroslava Dušková Inst. Pathol.,1st.

Similar presentations


Presentation on theme: "General Pathology Basic Principles of Cellular and Organ Pathology Steatosis. Mitochondrial and Peroxisomal Disorders. Jaroslava Dušková Inst. Pathol.,1st."— Presentation transcript:

1 General Pathology Basic Principles of Cellular and Organ Pathology Steatosis. Mitochondrial and Peroxisomal Disorders. Jaroslava Dušková Inst. Pathol.,1st Med. Faculty, Charles Univ. Prague

2 Steatosis (Fatty Change) Definition: acquired metabolic disorder with intracellular accumulation of lipid droplets (lipomatosis, adipositas - increase of fatty tissue amount)

3 Steatosis - morphology Macroscopy: yellowish - orange color of organs (+ carotenoids - lipochrom) Microscopy: microvacuolar cytoplasm - foamy cell macrovacuolar - unilocular

4 Steatosis hepatis LIVER - major organ of fat metabolism) abnormal accumulations of TRIGLYCERIDES within parenchymal cells Causes: alcohol abuse, protein malnutrition, diabetes mellitus, obesity, toxins,drugs, anoxia Macro: enlarged, yellow, greasy, soft Micro: small fatty, cytoplasmic droplets OR large vacuoles

5 Lipids accumulation in cells (sometimes causing cellular injury)  A normal cellular constituent accumulating in excess  An abnormal substance, usually a product of abnormal metabolism  A pigment

6 Processes resulting in abnormal intracellular accumulations  Abnormal metabolism of a normal endogenous substance (e. g. fatty liver)  Lack of an enzyme necessary for the metabolism of a normal or abnormal endogenous substance (e. g. lysosomal storage disease)

7 Clear Intracellular Vacuoles & adjunct techniques u accumulations of water neg. u lipides SUDAN, OIL RED u polysaccharides PAS, A-PAS

8 Lipidosis (thesaurismosis, lipid storage disease) Definition: inborn metabolic disorder with intracellular accumulation of lipid droplets (lysosomal enzymopathies)

9 Organelles Involved in Lipid Metabolism u Granular Endoplasmic Reticulum GER + Golgi app. u mitochondria u lysosomes

10 GER - l ipoprotein synthesis u enterocytes Apo B48 monoacylglycerols (fatty acids) triacylglycerols - chylomicrons u hepatocytes Apo B100 Very Low Density Lipoproteins

11 GER - l ipoprotein synthesis DISORDERS hepatocytes lack of Apo B100 synthesis - toxins toxic steatosis

12 Mitochondria - beta oxidation u fatty acids - carnitinacyltranpherase 1 + coenzyme A - carnitinacyltranspherase 2 beta oxidation

13 Mitochondria - beta oxidation DISORDERS u fatty acids - carnitinacyltranpherase 1 + coenzyme A - transport malfunction carnitinacyltranpherase 2 beta oxidation defect - hypoxia, anoxia hypoxic steatosis

14 Mitochondria - semiautonomous organelles (circular mtDNA, division) u isolated u network u spiral chain Outer membrane Inner membrane Cristae Matrix

15 Mitochondria - semiautonomous organelles (circular mtDNA, division) Function beta oxidation, Krebs cycle, OXFOS protein sorting & synthesis

16 Mitochondria - life cycle u division u majority of proteins coded in the nucleus u degradation in the autophagosomes

17 Mitochondria - genetics u circular mtDNA u haploid (maternal origin) u 2-20 mtDNA molecules in one mitochondrion u mtDNA molecules in one cell variable amplification

18 Mitochondria vs. Nucleus genetics u circular mtDNA u haploid (maternal origin) u 2-20 mtDNA molecules in one mitochondrion u mtDNA molecules in one cell u asynchrone replication u linear - chromosomes u diploid 23 pairs (maternal+paternal) u 46 macromolecules per one nucleus u 46 macromolecules per one cell u synchronized replication

19 Mitochondria vs. Nucleus genetics homoplasmia heteroplasmia polyplasmia only some copies normal + mutated mtDNA threshold effect u homozygotic u heterozygotic – carriers

20 Nuclear genes Ex. GRIM-19 Mt genes (Complex I, III, IV, V) Hürthle cell features Mitochondrial proliferation Activation of HIF-1 & Decreased apoptosis Tumourigenesis

21 Mitochondria - pathology u acquired – mitochondriosis – oncocytic change u inborn – enzymopathies

22 Mitochondria - pathology v inborn - enzymopathies Synthesis defects (partly nucleus coded): v urea and porphyrine v transport proteins v Krebs cycle enzymes succinate deh. v OXFOS nucleus & mitoch. coded

23 Lysosomes - l ipid hydrolysis u enzymes - lipase, phospholipase, sphingomyelinase etc…. membrane diffusion, reutilisation storage TAG, ChE transport from the cell - HDL, apo E

24 Lysosomes - l ipid hydrolysis DISORDERS u acquired - intensive endocytosis of lipids - histiocytes u hereditary - lipidoses, lipid storage dis.

25 Storage Diseases Def.: inborn errors of metabolism (mostly single gene abnormality) leading to an enzyme defect with subsequent accumulation of the substrate (& lack of the product) in tissues or organs „thesaurismoses“

26 Lipid Storage Diseases -1. DiseaseE- defAccum. Lipid Tissues Involved Tay-SachsHexos aminidase A GM2 ganglioside Brain, retina Gaucher  - Glucosidase Gluco cerebrosid Liver, spleen, bone marrow, brain Niemann- Pick Sphingo myelinase Sphingo myelin Brain, liver spleen

27 Lipid Storage Diseases – 2. DiseaseE- defAccum. Lipid Tissues Involved Metachro matic Leuco dystrophy Arylsulfat ase A SulfatidBrain, kidney, liver, peripheral nerves Fabry´s  -galactosid ase Ceramid trihexosid Skin, kidney Krabbe´sGalactosyl ceramidase Galactol cerebroside Brain

28 Extracellular Steatosis u blood: hyperlipemiae –increased size of lipoprotein particles (rel. decrease of the apoprotein component) –increased number of lipoprotein particles removed after oxidation via „scavenger receptors“ – resulting e.g. into aggravated & accelerated atherosclerosis, pancreatic necrosis –arcus senilis myringis, arcus senilis corneae

29 Lipids in Cell Signaling - 1 u Many of the lipids involved as second messengers in cell signaling pathways arise from the arachidonic acid (AA) pathway. u AA is an unsaturated fatty acid u a normal constituent of membrane phospholipids u released from the phospholipids by the actions of phospholipase A2 (PLA2).

30 Lipids in Cell Signaling - 2 u Prostaglandins (PG) are generated by the cyclooxygenase (COX). u There is a constitutive (COX-1) and an inducible cyclooxygenase (COX-2). u The cyclic endoperoxide intermediate is also a precursor of prostacyclin (PGI2) and thromboxane (TXA3).

31 Lipids in Cell Signaling - 3 u leukotrienes (LT) and lipoxins (LP), are derived directly from AA without the mediation of a cyclic endoperoxide. u LT induce inflammation by their chemotactic and degranulating actions on polymorphonuclear leucocytes (PML) u the amino acid containing LTs induce vasoconstriction and bronchoconstriction and are involved in asthma and anaphylaxis.

32 Peroxisomes - microbodies up to 2 microns - catalase Function Degradation: substrate oxidation (etanol) Anabolism: synthesis of prostaglandin, cholesterol, billiary acids, plasmalogens, gluconeogenesis, transamination

33 Peroxisomes - microbodies DISORDERS Lack of: Degradation: substrate oxidation e.g. etanol... Anabolism: synthesis of prostaglandin, cholesterol, billiary acids, gluconeogenesis, transamination...


Download ppt "General Pathology Basic Principles of Cellular and Organ Pathology Steatosis. Mitochondrial and Peroxisomal Disorders. Jaroslava Dušková Inst. Pathol.,1st."

Similar presentations


Ads by Google